by admin | Aug 4, 2025 | News & Opinions
By Christy Santhosh – Reuters News – Sarepta Therapeutics (SRPT.O), failed to win the European drug regulator’s backing for its muscle disorder gene therapy on Friday, as the company faces intense regulatory scrutiny after two recent patient deaths...
by admin | Aug 1, 2025 | News & Opinions
By Nature Communications Biology – Adipose tissue-derived mesenchymal stromal/stem cells (ADMSCs) represent a novel therapeutic intervention for Type 1 Diabetes (T1D). The attractiveness of ADMSCs is characterized by their immunomodulatory activities,...
by admin | Jul 31, 2025 | News & Opinions
By Genectic Engineering & Biotechnology – Phase I clinical trial results suggest that an antibody treatment, used in combination with other drugs, enabled stem cell transplants for three children with Fanconi anemia without toxic busulfan chemotherapy or...
by admin | Jul 30, 2025 | News & Opinions
By Emily Mullin – WIRED – Florida is the latest state to sidestep the authority of the Food and Drug Administration by allowing patients to access certain stem-cell treatments that have not been rigorously evaluated and approved. Under a new law that went...
by admin | Jul 29, 2025 | News & Opinions
By National institutes of Health – Chimeric antigen receptor (CAR) T cell therapies involve taking immune cells, called T cells, from a patient and engineering them to make a protein that lets them recognize and attack the patient’s cancer cells. CAR T cells...
by admin | Jul 28, 2025 | News & Opinions
By Danny Sullivan – Longevity.Technology – Healthspan Action Coalition’s Bernard Siegel says new state laws show the federal government needs to ‘get its act together’ on patient access to innovative therapies. As a member of the Florida Bar...
